Testis - Medium Biopsy 1-3 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Biopsy of testicular tissue.

₹370₹529

30% OFF

Testis - Medium Biopsy 1-3 cm: Comprehensive Medical Test Information Guide

Section 1: Why is it done?
- Test Purpose: This is a tissue sampling procedure that obtains a medium-sized sample (1-3 cm) of testicular tissue for histopathological examination and diagnosis of various testicular conditions.
- Primary Indications: Evaluation of testicular masses or nodules; Investigation of infertility and azoospermia (absence of sperm); Diagnosis of testicular pain or swelling; Assessment of suspected malignancy; Evaluation of testicular atrophy; Diagnosis of cryptorchidism complications
- Clinical Scenarios: Performed when imaging studies (ultrasound or MRI) show a suspicious lesion; When tumor markers are elevated; Following trauma with persistent symptoms; During infertility workup with abnormal semen analysis; When preserving testicular tissue is clinically important
Section 2: Normal Range
- Normal Histopathological Findings: Normal seminiferous tubules with intact basement membrane; Active spermatogenesis with all cell types present (spermatogonia, spermatocytes, spermatids, spermatozoa); Normal Sertoli cells and Leydig cells; Minimal to no inflammatory infiltrate; Clear tubular lumina with mature sperm; Normal interstitial tissue architecture
- Reference Ranges: Sample size: 1-3 cm (medium biopsy); Sperm concentration: >20 million/mL in ejaculate (if extracted); Johnson score: Grade I-VI (higher scores indicate better spermatogenesis)
- Interpretation Guidelines: Negative for malignancy: No cancer cells present; Normal architecture: Tissue structure appears unaffected; Benign findings: Presence of inflammation, cysts, or fibrosis is described; Positive for malignancy: Identifies specific cancer type and grade
Section 3: Interpretation
- Malignant Results: Germ cell tumors (seminoma, non-seminomatous types); Sex cord-stromal tumors (Leydig cell, Sertoli cell tumors); Lymphomas affecting the testis; Metastatic cancers; Requires staging studies and oncological consultation
- Benign Pathology: Azoospermia (complete absence of sperm production); Oligospermia (reduced sperm count); Maturation arrest (incomplete spermatogenesis); Fibrosis or scarring; Inflammatory orchitis; Hypogonadism; Atrophy of seminiferous tubules
- Factors Affecting Results: Age of patient; Previous chemotherapy or radiation exposure; Chronic infections; Systemic diseases; Medications affecting spermatogenesis; Sample quality and fixation; Site of biopsy within testis; Hormonal status
- Clinical Significance: Confirms or excludes malignancy; Guides treatment decisions (surgical intervention, chemotherapy, radiotherapy); Determines prognosis and staging; Assesses fertility potential; Identifies cause of infertility; Guides management of testicular masses
Section 4: Associated Organs
- Primary Organ System: Male reproductive system (testes/testicles); Endocrine system (hormone production); Lymphatic system (drainage and potential metastases)
- Associated Diseases and Conditions: Testicular cancer (seminoma, non-seminomatous germ cell tumors); Infertility and azoospermia; Cryptorchidism (undescended testicle); Testicular atrophy; Orchitis (testicular inflammation); Traumatic injury; Varicocele complications; Hypogonadism
- Potential Complications: Bleeding or hematoma at biopsy site; Infection (testiculitis); Chronic pain or discomfort; Reduced sperm production; Testicular atrophy; Vascular injury; Nerve damage; Allergic reaction to anesthesia
- Systemic Implications: Metastatic spread to lymph nodes, lungs, and other organs (if malignant); Hormonal imbalances affecting secondary sexual characteristics; Infertility impacting family planning; Psychological impact of cancer diagnosis
Section 5: Follow-up Tests
- If Malignancy Detected: Serum tumor markers (alpha-fetoprotein, beta-human chorionic gonadotropin, lactate dehydrogenase); Staging CT scans (abdomen, pelvis, chest); PET-CT imaging; Retroperitoneal lymph node dissection planning; Oncology consultation; Regular follow-up imaging and marker monitoring
- If Benign Pathology: Semen analysis (if infertility suspected); Hormonal testing (testosterone, FSH, LH levels); Repeat ultrasound if indicated; Sperm retrieval/cryopreservation for fertility treatment; Genetic counseling (if hereditary factors); Urology follow-up evaluation
- Monitoring Schedule: Malignant cases: Clinical and imaging surveillance every 3 months initially, then every 6 months, then annually; Benign cases: Follow-up as clinically indicated; Regular self-examination education; Annual urological evaluation
- Complementary Diagnostic Tests: Immunohistochemical staining for tumor markers; Flow cytometry analysis; Chromosome analysis (karyotyping); Gene mutation testing; MRI for better tissue characterization; Doppler ultrasound for blood flow assessment
Section 6: Fasting Required?
- Fasting Requirement: No - Fasting is NOT required for testicular biopsy
- Pre-Procedure Preparation: Light breakfast or normal meals are acceptable on morning of procedure; NPO (nothing by mouth) typically 4-6 hours if general anesthesia planned; Patient should void before procedure; Wear loose, comfortable clothing
- Medications to Avoid: Anticoagulants (warfarin, apixaban) - discontinue 5-7 days prior; Antiplatelet agents (aspirin, clopidogrel) - hold 3-5 days before; NSAIDs (ibuprofen, naproxen) - avoid for 1 week prior; Continue essential cardiac and blood pressure medications unless instructed; Discuss all medications with physician 1-2 weeks beforehand
- Anesthesia Considerations: Local anesthesia - minimal fasting required; Regional anesthesia (nerve block) - 4-6 hours NPO; General anesthesia - 6-8 hours NPO; Inform anesthesiologist of allergies and previous anesthetic reactions
- Post-Procedure Instructions: Resume normal diet as tolerated when alert; Hydration is encouraged; Avoid strenuous activity for 1-2 weeks; Rest with scrotal support; Ice application for first 24-48 hours; Pain management with prescribed medications; Sexual activity restriction as advised; Watch for signs of infection or excessive bleeding
- Additional Pre-Procedure Requirements: Pre-operative labs (CBC, coagulation studies, blood type); Physical examination; Imaging studies (ultrasound, MRI) to guide biopsy site; Consent form signature; Arrange transportation (required if sedation used); Informed discussion of risks and benefits; Baseline coagulation assessment if bleeding disorder suspected

How our test process works!